Dave Sharp

Person

The scientist who nominated Rapamycin for the Interventions Testing Program, recognizing its potential for cancer and aging even before widespread mTor research.

Mentioned in 2 videos

Videos Mentioning Dave Sharp

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

Peter Attia MD

A colleague of Randy Strong and an expert on mTOR, who suggested Rapamycin as an ITP candidate based on invertebrate data.

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.

Peter Attia MD

The scientist who nominated Rapamycin for the Interventions Testing Program, recognizing its potential for cancer and aging even before widespread mTor research.